Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Protein-Tyrosine Kinases. Found 11 abstracts

Xu Q, Malecka KL, Fink L, Jordan EJ, Duffy E, Kolander S, Peterson JR, Dunbrack RL. Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases. Science signaling. 2015 Dec;8(405):rs13.   PMCID: 4766099
Lal S, Burkhart RA, Beeharry N, Bhattacharjee V, Londin ER, Cozzitorto JA, Romeo C, Jimbo M, Norris ZA, Yeo CJ, Sawicki JA, Winter JM, Rigoutsos I, Yen TJ, Brody JR. HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells. Cancer Res. 2014 Feb 15;74(4):1128-40.   PMCID: 4353573
Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Apr;129(1):86-91.   PMCID: PMC 3712785
von Mehren M, Widmer N. Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?. Cancer Treat Rev. 2011 Jun;37(4):291-9.   PMCID: not NIH funded
Li C, Andrake M, Dunbrack R, Enders GH. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Mol Cell Biol. 2010 Jan;30(1):116-30.   PMCID: PMC2798281
Held-Warmkessel J. Targeted cancer. These "smart weapons" hit cancer in novel ways. Nursing. 2008 Sep;38(9):26-32.
Haas NB, Uzzo RG. Tyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer. Current treatment options in oncology. 2007 Jun;8(3):211-26.
Tarn C, Godwin AK. The molecular pathogenesis of gastrointestinal stromal tumors . Clin Colorectal Cancer. 2006 Nov;6 Suppl 1:S7-17.
Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):10983-5.   PMCID: PMC58668
Bellacosa A, Chan TO, Ahmed NN, Datta K, Malstrom S, Stokoe D, McCormick F, Feng J, Tsichlis P. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene. 1998 Jul 23;17(3):313-25.
Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (New York, NY). 1991 Oct 11;254(5029):274-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Protein-Tyrosine Kinases

Protein-Tyrosine Kinases metabolism genetics drug therapy antagonists & inhibitors Antineoplastic Agents Phosphorylation Protein-Serine-Threonine Kinases physiology Mice Amino Acid Sequence Molecular Sequence Data Protein Kinase Inhibitors pharmacology adverse effects Pyrimidines Drug Monitoring blood Cultured Tumor Cells Neoplastic Gene Expression Regulation methods therapeutic use Proto-Oncogene Proteins c-akt Female Piperazines Tertiary Protein Structure Aged chemistry Cell Cycle Proteins Proto-Oncogene Proteins Middle Aged Nuclear Proteins Gastrointestinal Stromal Tumors RNA Interference Angiogenesis Inhibitors Macrophage Colony-Stimulating Factor Receptor Drug Interactions G2 Phase Cyclin E Protein Databases etiology Protein Transport Patient Education as Topic analogs & derivatives Computer Simulation Karyopherins biosynthesis drug effects analysis Proto-Oncogene Proteins c-kit Neoplasm Metastasis Mitosis Neoplasms Male Monoclonal Antibodies HEK293 Cells EphA2 Receptor blood supply Sequence Alignment Renal Cell Carcinoma Nurse's Role Cell Nucleus Kidney Neoplasms Oncogene Protein v-akt Protein Kinases ELAV Proteins Recombinant Proteins Niacinamide Neoplasm Drug Resistance Patient Compliance p56(lck) Apoptosis Ovarian Neoplasms Neoplasm DNA Amino Acid Sequence Homology Diarrhea Platelet-Derived Growth Factor Receptors Transfection Stomatitis Cyclin-Dependent Kinase 2 Serine Hemorrhage Mutation Protein Conformation chemically induced S Phase Enzyme Activation enzymology Lymphocyte Specific Protein Tyrosine Kinase Retroviridae Protein Binding nursing Oncologic Nursing Point Mutation Drug Eruptions inhibitors Vascular Endothelial Growth Factor A 3T3 Cells Pathologic Neovascularization Mink Drug Delivery Systems 80 and over Aged Hypertension pharmacokinetics Mink Cell Focus-Inducing Viruses Cyclin A secondary Molecular Models Amino Acid Substitution Peritoneal Neoplasms Amino Acid Motifs Nucleic Acid Sequence Homology Local Neoplasm Recurrence Fallopian Tube Neoplasms Cell Line Threonine Glial Cell Line-Derived Neurotrophic Factor Conserved Sequence Neoplastic Cell Transformation Cell Nucleus Active Transport administration & dosage Pancreatic Ductal Carcinoma antagonists & Bone Marrow Diseases Site-Directed Mutagenesis Paronychia src Homology Domains Cytoplasmic and Nuclear Receptors Pancreatic Neoplasms Oncogenic Retroviridae Proteins DNA Damage Missense Mutation Indoles Genetic Vectors Interstitial Lung Diseases Oncogenes
Last updated on Wednesday, February 05, 2020